MeSH D000799 - angioedema
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Events Timeline
Commercial
Company Name | Drug Name | Trade Name | Patent Expires | Approval Date | Revenue | Period |
|---|---|---|---|---|---|---|
| Teva | Clemastine | Clemastine |  | 1992-04-21 |  |  |
| Perrigo | Clemastine | Clemastine |  | 1995-11-22 |  |  |
| GSK | Clemastine | Tavist |  | 1992-08-21 |  |  |
| Sandoz | Clemastine | Clemastine |  | 1993-10-31 |  |  |
| Novartis | Clemastine, Acetaminophen, Pseudoephedrine | Tavist |  | 1982-01-01 |  |  |
| Genus Lifesciences | Clemastine | Clemastine |  | 1994-06-30 |  |  |
1
2
3
>
Clinical Trials
Historical Success Rate
Phase 1
100%1/1
Phase 2
33%3/9
Phase 3
50%4/8
Approved: 4Overall Success rate: 17%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name | Phase 1 | Phase 2 | Phase 3 | Phase 4 | Drug Name |
|---|---|---|---|---|---|
1
2
>
© 2020-2023 Collaborative Drug Discovery Inc. (CDD) | Terms of Use